In this lecture, Dr Erin Goodhue will present on the history of apheresis and apheresis technologies, including centrifuge-based and membrane-based.
Lecture Objectives:
• Review terminology related to apheresis.
• Briefly discuss the history of apheresis.
• Describe centrifuge-based, and membrane-based apheresis technologies.
Run Time: 37
Lecture Instructor Bio(s)
Erin Goodhue (nee Meyer), DO, MPH
Director, Clinical Research and Development
Terumo BCT
Dr Erin Goodhue (nee Meyer) serves as the Director of Clinical Research and Development at Terumo BCT where she provides strategic clinical and scientific direction for new and novel TBCT products. Dr Goodhue leads a team of clinical and laboratory scientists as well as clinical regulatory and operations specialists who collaboratively evaluate, prioritize, and implement developed strategy including clinical trial protocol development and post market/phase IV studies.
Please click "Accept Sharing & Targeted Advertising" to enable full site functionality.
At this time, we are experiencing problems with broken links on our site. As an interim solution, for full site functionality you must enable functional and advertising cookies. If you continue to opt-out of these cookies, some content on our site may not be viewable.
We use functional cookies to analyze your use of the site, improve performance and provide a better customer experience. We use advertising cookies to allow us, through certain data assigned and obtained from the user's device, to store or share with third parties information related to user's browsing activity in our website, in order to create an advertising profile and place relevant advertising in our website or those third parties websites. For more information about how Abbott uses cookies please see our Cookie Policy and Privacy Policy.